315 related articles for article (PubMed ID: 23140648)
21. Haematological side effects of clozapine: patient characteristics.
Miller PR; Cutten AE
N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
[TBL] [Abstract][Full Text] [Related]
22. Clozapine treatment in Australia: a review of haematological monitoring.
Copolov DL; Bell WR; Benson WJ; Keks NA; Strazzeri DC; Johnson GF
Med J Aust; 1998 May; 168(10):495-7. PubMed ID: 9631674
[TBL] [Abstract][Full Text] [Related]
23. [Hematologic effects of clozapine: evaluation of the international experience].
Lamarque V
Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344
[TBL] [Abstract][Full Text] [Related]
24. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
[TBL] [Abstract][Full Text] [Related]
25. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
Bauer M; Mackert A
J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
[TBL] [Abstract][Full Text] [Related]
26. Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted.
Lahdelma L; Appelberg B
J Clin Psychiatry; 2012 Jun; 73(6):837-42. PubMed ID: 22480452
[TBL] [Abstract][Full Text] [Related]
27. Diabetic ketoacidosis in Denmark Incidence and mortality estimated from public health registries.
Henriksen OM; Røder ME; Prahl JB; Svendsen OL
Diabetes Res Clin Pract; 2007 Apr; 76(1):51-6. PubMed ID: 16959363
[TBL] [Abstract][Full Text] [Related]
28. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
29. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
Nielsen J; Correll CU; Manu P; Kane JM
J Clin Psychiatry; 2013 Jun; 74(6):603-13; quiz 613. PubMed ID: 23842012
[TBL] [Abstract][Full Text] [Related]
30. Review and management of clozapine side effects.
Miller DD
J Clin Psychiatry; 2000; 61 Suppl 8():14-7; discussion 18-9. PubMed ID: 10811238
[TBL] [Abstract][Full Text] [Related]
31. White blood cell monitoring during long-term clozapine treatment.
Cohen D; Monden M
Am J Psychiatry; 2013 Apr; 170(4):366-9. PubMed ID: 23545791
[TBL] [Abstract][Full Text] [Related]
32. Do white-cell count spikes predict agranulocytosis in clozapine recipients?
Alvir JM; Lieberman JA; Safferman AZ
Psychopharmacol Bull; 1995; 31(2):311-4. PubMed ID: 7491384
[TBL] [Abstract][Full Text] [Related]
33. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
Every-Palmer S; Ellis PM
CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
[TBL] [Abstract][Full Text] [Related]
34. [Clozapine and diabetic ketoacidosis].
Kristensen SH; Pørksen NK
Ugeskr Laeger; 2003 Jan; 165(5):475-6. PubMed ID: 12599849
[TBL] [Abstract][Full Text] [Related]
35. [A case study; ethnicity and clozapine, a risky combination?].
Laan WJ; Ramlal D
Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
[TBL] [Abstract][Full Text] [Related]
36. Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012).
Balda MV; Garay OU; Papale RM; Bignone I; Bologna VG; Brandolini A; Prokopez CR; Balasini JI; Baldessarini RJ; Daray FM
Int Clin Psychopharmacol; 2015 Mar; 30(2):109-14. PubMed ID: 25486383
[TBL] [Abstract][Full Text] [Related]
37. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
Maskasame S; Krisanaprakornkit T; Khiewyoo J
J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
[TBL] [Abstract][Full Text] [Related]
38. [Hematologic effects of clozapine: a review of the international experience].
Lamarque V
Encephale; 1996 Dec; 22 Spec No 6():35-6. PubMed ID: 9102319
[TBL] [Abstract][Full Text] [Related]
39. Reintroduction of clozapine after perforation of the large intestine--a case report and review of the literature.
Ikai S; Suzuki T; Uchida H; Mimura M; Fujii Y
Ann Pharmacother; 2013; 47(7-8):e31. PubMed ID: 23757383
[TBL] [Abstract][Full Text] [Related]
40. [Frequent cases of agranulocytosis due to clozapin (leponex) in eastern Switzerland].
Jungi WF; Fischer J; Senn HJ; Hartlapp J; Pöldinger W; Kunz H; Krupp P
Schweiz Med Wochenschr; 1977 Dec; 107(49):1861-4. PubMed ID: 929152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
